Merit Medical Systems Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $1.6B+16.4% YoYTTM through 30 Jun 2026
Net Income $145.6M+20.9% YoYTTM through 30 Jun 2026
Free Cash Flow $203.2MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 48.4% |
| EBITDA Margin | 20.6% |
| Operating Margin | 11.6% |
| Net Margin | 9.2% |
Returns
8.6%ROE
5.1%ROA
7.4%ROIC
Balance Sheet Health
Debt / Equity0.46x
Current Ratio4.20x
Net Debt$259.4M
Cash & Equivalents$448.7M
Quality Metrics
Altman Z-Score4.22
Piotroski F-Score7 / 9
FCF Margin12.9%
Rule of 4016.5
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $1.5B
Diluted EPS$2.43TTMFY2025: $2.13
Dividend
No dividend
Capital Allocation
Capex Intensity5.1%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Foundational | +5.5% | View detailsExpected to grow in line with multi-year targets. | |
| Therapeutic | +12.0% | View detailsExpected to drive future growth, supported by the ViewPoint Medical acquisition. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.